Body Central Corp. (BODY) Reports In-Line Q1 EPS; Guides Q2, FY12 Below Views
Tweet Send to a FriendGet Alerts BODY Hot Sheet
Trade BODY Now!
Body Central Corp. (NASDAQ: BODY) reported Q1 EPS of $0.36, in-line with the analyst estimate of $0.36. Revenue for the quarter came in at $82.7 million versus the consensus estimate of $82.12 million.
Body Central Corp. sees Q2 2012 EPS of $0.26-$0.28, versus the consensus of $0.37. Body Central Corp. sees Q2 2012 revenue of $80-$82 million, versus the consensus of $86.6 million.
Body Central Corp. sees FY2012 EPS of $1.34-$1.38, versus the consensus of $1.52. Body Central Corp. sees FY2012 revenue of $333-$337 million, versus the consensus of $346 million.
For earnings history and earnings-related data on Body Central Corp. (BODY) click here.
Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here
Body Central Corp. sees Q2 2012 EPS of $0.26-$0.28, versus the consensus of $0.37. Body Central Corp. sees Q2 2012 revenue of $80-$82 million, versus the consensus of $86.6 million.
Body Central Corp. sees FY2012 EPS of $1.34-$1.38, versus the consensus of $1.52. Body Central Corp. sees FY2012 revenue of $333-$337 million, versus the consensus of $346 million.
For earnings history and earnings-related data on Body Central Corp. (BODY) click here.
Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here
You May Also Be Interested In
- Abercrombie & Fitch Co. (ANF) Misses Q1 EPS by 4c; Guides FY Below Views
- Shoe Carnival, Inc. (SCVL) Tops Q1 EPS by 6c, Guides Q2 In-Line
- Marvell Technology Group (MRVL) Tops Q1 EPS by 5c; Issues Solid Outlook
Create E-mail Alert Related Categories
Earnings, Guidance, Hot Guidance, Trading HaltsRelated Entities
EarningsLogin with Facebook
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!

